InsidersTradesSigma
Track the 智飞生物 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 智飞生物 has logged 1 insider filings. Market capitalisation: €30.9bn. The latest transaction was reported on 14 March 2022 (Sale). Among the most active insiders: 蒋仁生. The full history is free.
Analysts rate 智飞生物 Buy (bullish), based on 3 analysts. Average price target: CN¥21.17.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
智飞生物 is a company focused on the health and pharmaceutical sector, specializing in the development and production of vaccines. It is listed on the XSHE market.